W Ludo van der Pol Selected Research

Autoimmune Diseases (Autoimmune Disease)

1/2021	Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.
1/2019	Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Ludo van der Pol Research Topics

Disease

19	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 12/2023 - 01/2016
4	Disease Progression 01/2020 - 04/2012
3	COVID-19 05/2023 - 05/2022
3	Inflammation (Inflammations) 01/2023 - 05/2014
3	Muscle Weakness 01/2022 - 07/2014
2	Breakthrough Infections 05/2024 - 06/2022
2	Neuromuscular Diseases (Neuromuscular Disease) 10/2023 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2019
2	Dermatomyositis (Dermatopolymyositis) 01/2021 - 01/2019
2	Muscular Diseases (Myopathy) 01/2020 - 01/2019
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2019 - 03/2010
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2017 - 08/2017
1	Infections 05/2024
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	AIDS-Related Complex (ARC) 06/2022
1	Eosinophilic Fasciitis 01/2021
1	Localized Scleroderma (Morphea) 01/2021
1	Sudden Infant Death (SID) 01/2021
1	Guillain-Barre Syndrome 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 02/2020
1	Rhabdomyolysis 01/2020
1	Fatigue 03/2019
1	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 03/2019
1	Paraproteinemias (Monoclonal Gammopathy) 01/2019
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Hypertrophy 01/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Muscular Atrophy (Muscle Atrophy) 10/2017
1	Spinal Diseases (Disease, Spinal) 10/2017
1	Vomiting 01/2017
1	Nasopharyngitis 01/2017
1	Cough 01/2017
1	Fever (Fevers) 01/2017
1	Trifunctional Protein Deficiency With Myopathy And Neuropathy 05/2014
1	VLCAD deficiency 05/2014
1	Contracture 03/2014
1	Asphyxia (Suffocation) 04/2012
1	Brown-Vialetto-Van Laere syndrome 02/2011
1	Deafness (Deaf Mutism) 02/2011

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2016
4	AntibodiesIBA 05/2024 - 08/2015
4	nusinersenIBA 12/2023 - 01/2021
3	Immunosuppressive Agents (Immunosuppressants)IBA 05/2024 - 06/2022
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2016
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 03/2010
3	Immunoglobulin M (IgM)IBA 01/2019 - 08/2015
2	Complement System Proteins (Complement)IBA 01/2023 - 08/2015
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2023 - 01/2018
2	olesoximeIBA 12/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 08/2017 - 01/2016
1	Immunomodulating AgentsIBA 05/2023
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2023
1	AntigensIBA 06/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	ProteomeIBA 12/2021
1	FetuinsIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	InterferonsIBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2021
1	Thrombospondin 1IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Galectin 1 (LGALS1)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	AngiopoietinsIBA 01/2021
1	TIE Receptors (TIE Receptor Tyrosine Kinases)IBA 01/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021
1	plastinIBA 02/2020
1	Profilins (Profilin)IBA 02/2020
1	DNA-Binding Proteins (DNA Binding Protein)IBA 02/2020
1	CarbohydratesIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 03/2019
1	EnzymesIBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	ParaproteinsIBA 01/2018
1	Metalloproteases (Metalloproteinases)IBA 10/2017
1	LigandsIBA 10/2017
1	Clostridium perfringens epsilon-toxinIBA 01/2015
1	Oxidoreductases (Dehydrogenase)IBA 05/2014
1	Coenzyme A (CoA)IBA 05/2014
1	Carnitine palmitoyl transferase 2 deficiencyIBA 05/2014
1	LipidsIBA 05/2014
1	Nonsense Codon (Nonsense Mutation)IBA 03/2014
1	CreatineIBA 04/2012
1	Hydroxyurea (Hydrea)FDA LinkGeneric 04/2012
1	Riboflavin (Vitamin B2)FDA LinkGeneric 02/2011

Therapy/Procedure

7	Therapeutics 01/2023 - 03/2010
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2020
1	Exercise Therapy (Therapy, Exercise) 10/2023
1	MAP protocol 04/2023
1	Breathing Exercises 03/2023
1	Drug Therapy (Chemotherapy) 12/2019
1	Resistance Training 03/2019
1	Bite Force (Occlusal Forces) 02/2016